Enhabit, Inc. (NYSE:EHAB) Shares Sold by Jane Street Group LLC

Jane Street Group LLC trimmed its holdings in Enhabit, Inc. (NYSE:EHAB - Free Report) by 68.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 280,195 shares of the company's stock after selling 620,889 shares during the period. Jane Street Group LLC owned about 0.56% of Enhabit worth $2,188,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Quantbot Technologies LP acquired a new stake in shares of Enhabit during the 4th quarter valued at approximately $45,000. Corient Private Wealth LLC bought a new position in Enhabit during the 4th quarter worth $79,000. Quarry LP grew its stake in Enhabit by 692.6% during the 4th quarter. Quarry LP now owns 10,811 shares of the company's stock worth $84,000 after buying an additional 9,447 shares during the last quarter. Stoneridge Investment Partners LLC grew its stake in Enhabit by 22.6% during the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company's stock worth $98,000 after buying an additional 2,308 shares during the last quarter. Finally, Boothbay Fund Management LLC bought a new position in Enhabit during the 4th quarter worth $106,000.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Stock Performance

EHAB traded down $0.17 during trading on Thursday, reaching $10.27. 214,108 shares of the company were exchanged, compared to its average volume of 457,595. The stock has a market cap of $519.79 million, a P/E ratio of -4.42 and a beta of 1.61. The firm has a 50 day moving average of $8.68 and a 200 day moving average of $8.29. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $10.79.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.07 by $0.03. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The firm had revenue of $259.90 million during the quarter, compared to the consensus estimate of $266.11 million. On average, sell-side analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.